NASDAQ:VCEL

Vericel Stock Insider Trading

Healthcare > Biotechnology

Buy VCEL

*Your capital is at risk

$45.96

-1.65 (-3.47%)

At Close: Jul 31, 2026

Vericel Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.70. In total, the insiders bought 453K and sold 153.78K VCEL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-64.70
● Buy	453K shares
● Sell	153.78K shares
72% Buy Activity Moderate Negative Correlation
Buy Signal Low Confidence Feb 19, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -64.7. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 24, 2026 Buy	Common Stock M-Exempt	Hopper Jonathan Mark Chief Medical Officer	Officer	350 Value: $13.4K
Feb 24, 2026 Sell	Common Stock F-InKind	Hopper Jonathan Mark Chief Medical Officer	Officer	1 335 Value: $50.9K
Feb 24, 2026 Buy	Common Stock M-Exempt	Hopper Jonathan Mark Chief Medical Officer	Officer	1 500 Value: $57.4K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Colangelo Dominick President And CEO	CEO / President	18 250 Value: $698.1K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Colangelo Dominick President And CEO	CEO / President	18 250 Value: $698.1K
Feb 24, 2026 Sell	Common Stock F-InKind	Halpin Michael Chief Operating Officer	C-Suite Officer	2 486 Value: $94.7K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Halpin Michael Chief Operating Officer	C-Suite Officer	5 250 Value: $200.8K
Feb 24, 2026 Buy	Common Stock M-Exempt	Halpin Michael Chief Operating Officer	C-Suite Officer	5 250 Value: $200.8K
Feb 24, 2026 Sell	Common Stock F-InKind	Halpin Michael Chief Operating Officer	C-Suite Officer	2 486 Value: $95.1K
Feb 24, 2026 Buy	Common Stock M-Exempt	Halpin Michael Chief Operating Officer	C-Suite Officer	5 250 Value: $200.8K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Halpin Michael Chief Operating Officer	C-Suite Officer	5 250 Value: $200.8K
Feb 24, 2026 Buy	Common Stock M-Exempt	Colangelo Dominick President And CEO	CEO / President	18 250 Value: $698.1K
Feb 24, 2026 Sell	Common Stock F-InKind	Colangelo Dominick President And CEO	CEO / President	8 824 Value: $336.1K
Feb 24, 2026 Buy	Common Stock M-Exempt	Colangelo Dominick President And CEO	CEO / President	18 250 Value: $698.1K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Hopper Jonathan Mark Chief Medical Officer	Officer	3 150 Value: $120.5K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Hopper Jonathan Mark Chief Medical Officer	Officer	1 500 Value: $57.4K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Hopper Jonathan Mark Chief Medical Officer	Officer	1 500 Value: $57.4K
Feb 24, 2026 Sell	Common Stock F-InKind	Siegal Jonathan Principal Accounting Officer	Officer	627 Value: $23.9K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Siegal Jonathan Principal Accounting Officer	Officer	1 540 Value: $58.9K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Siegal Jonathan Principal Accounting Officer	Officer	1 875 Value: $71.7K
Feb 24, 2026 Sell	Common Stock F-InKind	Mara Joseph Anthony Jr Chief Financial Officer	C-Suite Officer	1 358 Value: $51.7K
Feb 24, 2026 Buy	Restricted Stock Unit M-Exempt	Mara Joseph Anthony Jr Chief Financial Officer	C-Suite Officer	4 625 Value: $176.9K
Feb 24, 2026 Sell	Common Stock F-InKind	Hopper Jonathan Mark Chief Medical Officer	Officer	636 Value: $24.3K
Feb 24, 2026 Buy	Common Stock M-Exempt	Hopper Jonathan Mark Chief Medical Officer	Officer	1 500 Value: $57.4K
Feb 24, 2026 Buy	Common Stock M-Exempt	Hopper Jonathan Mark Chief Medical Officer	Officer	3 150 Value: $120.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT VERICEL CORPORATION

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epic...

Read Full Profile Here